ICU Medical Price to Sales Ratio 2010-2024 | ICUI
Historical PS ratio values for ICU Medical (ICUI) over the last 10 years. The current P/S ratio for ICU Medical as of May 09, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| ICU Medical P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-09 | 138.30 | 1.41 | |
| 2024-12-31 | 155.17 | $97.78 | 1.59 |
| 2024-09-30 | 182.22 | $96.35 | 1.89 |
| 2024-06-30 | 118.75 | $94.95 | 1.25 |
| 2024-03-31 | 107.32 | $93.32 | 1.15 |
| 2023-12-31 | 99.74 | $93.60 | 1.07 |
| 2023-09-30 | 119.01 | $93.42 | 1.27 |
| 2023-06-30 | 178.19 | $95.72 | 1.86 |
| 2023-03-31 | 164.96 | $96.38 | 1.71 |
| 2022-12-31 | 157.48 | $95.67 | 1.65 |
| 2022-09-30 | 150.60 | $87.09 | 1.73 |
| 2022-06-30 | 164.39 | $77.54 | 2.12 |
| 2022-03-31 | 222.64 | $68.89 | 3.23 |
| 2021-12-31 | 237.34 | $60.58 | 3.92 |
| 2021-09-30 | 233.38 | $59.79 | 3.90 |
| 2021-06-30 | 205.80 | $59.10 | 3.48 |
| 2021-03-31 | 205.44 | $58.39 | 3.52 |
| 2020-12-31 | 214.49 | $59.01 | 3.64 |
| 2020-09-30 | 182.76 | $58.81 | 3.11 |
| 2020-06-30 | 184.31 | $58.34 | 3.16 |
| 2020-03-31 | 201.77 | $58.74 | 3.43 |
| 2019-12-31 | 187.12 | $58.82 | 3.18 |
| 2019-09-30 | 159.60 | $59.93 | 2.66 |
| 2019-06-30 | 251.91 | $60.75 | 4.15 |
| 2019-03-31 | 239.33 | $62.95 | 3.80 |
| 2018-12-31 | 229.63 | $64.98 | 3.53 |
| 2018-09-30 | 282.75 | $66.97 | 4.22 |
| 2018-06-30 | 293.65 | $68.10 | 4.31 |
| 2018-03-31 | 252.40 | $68.12 | 3.71 |
| 2017-12-31 | 216.00 | $63.41 | 3.41 |
| 2017-09-30 | 185.85 | $51.21 | 3.63 |
| 2017-06-30 | 172.50 | $40.56 | 4.25 |
| 2017-03-31 | 152.70 | $29.53 | 5.17 |
| 2016-12-31 | 147.35 | $22.18 | 6.64 |
| 2016-09-30 | 126.38 | $22.11 | 5.72 |
| 2016-06-30 | 112.75 | $21.68 | 5.20 |
| 2016-03-31 | 104.10 | $21.12 | 4.93 |
| 2015-12-31 | 112.78 | $20.81 | 5.42 |
| 2015-09-30 | 109.50 | $20.44 | 5.36 |
| 2015-06-30 | 95.66 | $20.25 | 4.72 |
| 2015-03-31 | 93.14 | $20.25 | 4.60 |
| 2014-12-31 | 81.90 | $19.99 | 4.10 |
| 2014-09-30 | 64.18 | $19.98 | 3.21 |
| 2014-06-30 | 60.81 | $20.39 | 2.98 |
| 2014-03-31 | 59.88 | $20.43 | 2.93 |
| 2013-12-31 | 63.71 | $20.61 | 3.09 |
| 2013-09-30 | 67.93 | $21.12 | 3.22 |
| 2013-06-30 | 72.06 | $21.21 | 3.40 |
| 2013-03-31 | 58.95 | $21.33 | 2.76 |
| 2012-12-31 | 60.93 | $21.66 | 2.81 |
| 2012-09-30 | 60.48 | $21.45 | 2.82 |
| 2012-06-30 | 53.38 | $21.35 | 2.50 |
| 2012-03-31 | 49.16 | $21.52 | 2.28 |
| 2011-12-31 | 45.00 | $21.33 | 2.11 |
| 2011-09-30 | 36.80 | $21.27 | 1.73 |
| 2011-06-30 | 43.70 | $21.39 | 2.04 |
| 2011-03-31 | 43.78 | $20.98 | 2.09 |
| 2010-12-31 | 36.50 | $20.45 | 1.78 |
| 2010-09-30 | 37.29 | $19.60 | 1.90 |
| 2010-06-30 | 32.17 | $17.66 | 1.82 |
| 2010-03-31 | 34.45 | $16.16 | 2.13 |
| 2009-12-31 | 36.44 | $15.25 | 2.39 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.516B | $2.382B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.138B | 28.03 |
| Boston Scientific (BSX) | United States | $152.812B | 38.26 |
| Stryker (SYK) | United States | $145.981B | 30.52 |
| EssilorLuxottica (ESLOY) | France | $128.807B | 0.00 |
| Medtronic (MDT) | Ireland | $107.246B | 15.66 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.937B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.673B | 27.10 |
| ResMed (RMD) | United States | $35.644B | 26.77 |
| GE HealthCare Technologies (GEHC) | United States | $32.281B | 15.33 |
| Agilent Technologies (A) | United States | $30.991B | 20.47 |
| Terumo (TRUMY) | Japan | $28.175B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.624B | 16.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.817B | 12.09 |
| Insulet (PODD) | United States | $18.083B | 70.99 |
| Baxter (BAX) | United States | $16.011B | 11.95 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.408B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.962B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.751B | 22.82 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 14.04 |
| Prestige Consumer Healthcare (PBH) | United States | $4.312B | 19.21 |
| Perrigo (PRGO) | Ireland | $3.684B | 9.34 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.417B | 14.88 |
| Envista Holdings (NVST) | United States | $3.012B | 25.03 |
| QuidelOrtho (QDEL) | United States | $2.459B | 16.96 |
| GN Store Nord (GNNDY) | Denmark | $2.020B | 16.73 |
| LeMaitre Vascular (LMAT) | United States | $1.841B | 41.16 |
| AtriCure (ATRC) | United States | $1.544B | 0.00 |
| Neogen (NEOG) | United States | $1.300B | 16.64 |
| Green Thumb Industries (GTBIF) | United States | $1.234B | 27.76 |
| Kestra Medical Technologies (KMTS) | United States | $1.162B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.130B | 11.47 |
| BioLife Solutions (BLFS) | United States | $1.062B | 0.00 |
| InMode (INMD) | Israel | $0.990B | 9.06 |
| Phibro Animal Health (PAHC) | United States | $0.901B | 11.53 |
| Evolus (EOLS) | United States | $0.651B | 0.00 |
| CeriBell (CBLL) | United States | $0.616B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.592B | 0.00 |
| Owens & Minor (OMI) | United States | $0.540B | 4.48 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.445B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.405B | 0.00 |
| Surmodics (SRDX) | United States | $0.389B | 0.00 |
| Omeros (OMER) | United States | $0.368B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.356B | 13.11 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.270B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.267B | 47.50 |
| Verano Holdings (VRNOF) | United States | $0.266B | 0.00 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| ZimVie (ZIMV) | United States | $0.256B | 11.63 |
| Viemed Healthcare (VMD) | United States | $0.254B | 21.40 |
| Canopy Growth (CGC) | Canada | $0.246B | 0.00 |
| Quanterix (QTRX) | United States | $0.214B | 0.00 |
| Biote (BTMD) | United States | $0.205B | 5.75 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| High Tide (HITI) | Canada | $0.193B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.25 |
| TriSalus Life Sciences (TLSI) | United States | $0.167B | 0.00 |
| Brainsway (BWAY) | Israel | $0.167B | 52.18 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.33 |
| Organigram Global (OGI) | Canada | $0.149B | 0.00 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| Exagen (XGN) | United States | $0.111B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.080B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| Fonar (FONR) | United States | $0.078B | 10.91 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| United Health Products (UEEC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Apyx Medical (APYX) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 58.50 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.74 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |